// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Smoking cessation in patients with Diabetes Mellitus (DM

Aliki Korkontzelou - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Champix

Using QI methodology to improve training & delivery of smoking cessation advice amongst Portsmouth inpatients to improve long term outcomes

Laura Wiffen - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Quality Improvement Project to Increase Smoking Cessation in a Hospital Acute Cardio-Respiratory Admissions Unit

Daniela Nicoara - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Experience of an integrated smoking cessation practitioner on inpatient referral and treatment of tobacco dependency in a district general hospital

Dinesh Shrikrishna - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Aortic stiffness in young smokers classified as chronic bronchitis: the British Lung Foundation (BLF Early COPD cohort

Alex Jenkins - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Inhaler recycling prevalence in a secondary care clinic in England

Ruth De Vos - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Vaping: more than smoke and mirrors?

Nitika Kaushal - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Intra-alveolar neutrophil-derived microvesicles predict development of primary graft dysfunction after lung transplantation

Sanooj Soni - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Other

Primary graft dysfunction

N/A

Elevated lung clearance index (LCI as an early marker of future bronchiolitis obliterans (BOS post lung transplant

Madeleine Driskel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Obliterative bronchiolitis

N/A

Mycobacterium tuberculosis modulates mitochondrial function in human macrophages

Claudio Bussi - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

2-Deoxy-D-Glucose

Screening of the under-served population of Luton for tuberculosis and blood-borne viruses

Syed Tariq - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Evaluation of Th9 and Th22 cells within pleural effusions of tuberculosis and non-tuberculosis patients

Neda Dalil Roofchayee - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Oesophageal TB secondary to mediastinal lymphadenitis: a London tertiary centre experience

Hannah Gordon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Utility of pleural fluid glucose measurement in TB pleural effusions

Charlotte Carter - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

A retrospective evaluation of the management of ocular tuberculosis in Southampton

Sophie Knipe - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

A UK cost comparison of amikacin therapy with bedaquiline, for drug resistant tuberculosis

Kavina Manalan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Bedaquiline

Evaluation of inflammatory mediators of pleural effusion in tuberculosis and non-tuberculosis patients

Neda Dalil Roofchayee - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Barriers and facilitators of a latent tuberculosis screening and treatment programme of recent migrants

Kathryn O'Brien - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Evaluation of DestiNA ‘spin-tube’ technology – a novel test for the diagnosis of tuberculosis and mycobacteriosis

Tatiana Smirnova - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Diagnostic accuracy of TB PCR in mediastinal lymph node TB in a UK centre using EBUS-TBNA

Mirae Park - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved